Literature DB >> 1645761

Serum antibodies against respiratory tract viruses in episodes of acute otitis media.

G Harsten1, K Prellner, B Löfgren, O Kalm.   

Abstract

Although the findings of epidemiological studies have suggested viral respiratory tract infection (RTI) to be crucially involved in the development of acute otitis media (AOM), the relationship between AOM and viral RTI remains unclear. Serum samples, obtained in the acute and convalescent phases of 57 AOM episodes (in 35 children during the first three years of life) were analysed for IgG antibodies against influenza A viruses, influenza B viruses, parainfluenza virus type 1, respiratory syncytial virus and adenoviruses. One third of the AOM episodes (18/57) could be related to viral RTI, as evidenced by significant increases in viral serum antibody activity. Treatment failure occurred in four AOM episodes where increases in serum viral antibody activity were noted. In three of these failures, antibiotic treatment was unsuccessful despite the bacterial strains not being resistant to the drug used. This suggests that concomitant viral infection may be a determinant of treatment outcome in some AOM episodes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645761     DOI: 10.1017/s0022215100115920

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Evidence for transudation of specific antibody into the middle ears of parenterally immunized chinchillas after an upper respiratory tract infection with adenovirus.

Authors:  L O Bakaletz; K A Holmes
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 2.  Immunopathogenesis of polymicrobial otitis media.

Authors:  Lauren O Bakaletz
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

3.  Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media.

Authors:  Johanna Nokso-Koivisto; Riitta Räty; Soile Blomqvist; Marjaana Kleemola; Ritva Syrjänen; Anne Pitkäranta; Terhi Kilpi; Tapani Hovi
Journal:  J Med Virol       Date:  2004-02       Impact factor: 2.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.